Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
about
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003Treatment of menopausal symptoms with Er-xian decoction: a systematic review.Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010.Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative.Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009Does hormone therapy counter the beneficial effects of physical activity on breast cancer risk in postmenopausal women?Sources of information influencing the state-of-the-science gap in hormone replacement therapy usageChanges in postmenopausal hormone therapy use since 1988.Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults.Exogenous hormone use and meningioma risk: what do we tell our patients?HT update: spotlight on estradiol/norethindrone acetate combination therapyBioidentical hormone therapy: Nova Scotia pharmacists' knowledge and beliefsProvider attributes associated with hormone therapy prescribing frequency.Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies.Colorectal cancer in women: hormone replacement therapy and chemoprevention.Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.Combined hormone therapy at menopause and breast cancer: a warning--short-term use increases risk.Estradiol topical emulsion for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.Use of hormone replacement therapy, 1998-2007: sustained impact of the Women's Health Initiative findings.Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.Non-health Care Facility Medication Errors Associated with Hormones and Hormone Antagonists in the United States.
P2860
Q21254698-B013D744-AB87-4F08-8DE9-A3353DD02971Q33331755-E1E68490-9941-49FB-BBC3-C5309AD8A2ABQ34047699-9AE35A35-985B-4486-88E7-EA8B086F5D37Q34115930-167A178E-ABE3-478F-B5EA-A1F24746BDC9Q34232032-79FEEE45-EA6A-48EA-86BD-BCED2D38D70BQ34414882-DBE16A2F-E3A1-494E-B56E-710371B0171FQ35068765-A3355906-904F-4B6F-B243-658F2852FA51Q35588438-8F1D32DE-2845-4B23-9F99-5D1127FA9134Q36269803-E11758C0-6CB5-4A6B-9C5F-0AD6032587CDQ36334352-EB59D30F-0920-49F9-964A-83CA6BF831FCQ36436644-6DF3E029-5461-4360-B8B6-B6BFF53CBD09Q36841311-B6A1BCBC-EA9B-4D81-BE8B-465FDCAE9067Q36853980-77340F2F-83F4-4C55-AA65-36E029E42E03Q36892918-BC7E6DBC-5C8B-44DC-87CD-DEEF94AF27BDQ37190890-88925B9A-8E8E-4683-AC73-E329047B8CFFQ37261100-1E346DBF-FC1C-4CA2-A676-F2D37D84A2A2Q37385612-36133AE9-9F9E-4F69-A4B2-14F3295FC981Q38011783-D5B2B8ED-3CF1-41F9-A460-91E2D1C9030CQ42167610-5051D2F9-FE0C-4F0C-980F-6B2DE58E7516Q42920762-D62080B2-D936-46B6-8DDE-3644A61F0F3BQ43267074-133F349F-72BA-4CAC-B960-139CBCC7AF26Q46133388-25103194-3D9E-49A0-9776-D058D18C4DD2Q46447921-75E2B9F2-BB05-4938-B96A-CB722E0764C2Q47987919-B3D9B750-4955-48AD-840D-EEBCACF7E735
P2860
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@ast
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@en
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@nl
type
label
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@ast
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@en
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@nl
prefLabel
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@ast
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@en
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@nl
P1476
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
@en
P2093
Esther Hing
Kate M Brett
P356
10.1097/01.AOG.0000220502.77153.5A
P407
P577
2006-07-01T00:00:00Z